Alembic Pharma's Panelav unit successfully completes USFDA inspection
Alembic Pharmaceuticals has successfully completed the United States Food and Drug Administration (USFDA) inspection for its Oral Solid
Formulation Facility (F-I) located at Panelav. This was a scheduled GMP inspection and was successfully completed without any Form 483 observation. The inspection was conducted from 17 July 2024 to 26 July 2024.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jul 26 2024 | 1:36 PM IST